Loading…

Symptom scores and medication treatment patterns in children with ADHD versus autism

•Psychotropic use was analyzed in 1407 children with autism and 1036 with ADHD.•Symptom scores for medicated children were far higher than for unmedicated children.•Percent prescribed a psychotropic did not differ between ADHD-Combined and autism.•Children with ADHD-Inattentive were least impaired a...

Full description

Saved in:
Bibliographic Details
Published in:Psychiatry research 2020-06, Vol.288, p.112937-112937, Article 112937
Main Authors: Mayes, Susan D., Waxmonsky, James G., Baweja, Raman, Mattison, Richard E., Memon, Hasan, Klein, Melanie, Hameed, Usman, Waschbusch, Daniel
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3
cites cdi_FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3
container_end_page 112937
container_issue
container_start_page 112937
container_title Psychiatry research
container_volume 288
creator Mayes, Susan D.
Waxmonsky, James G.
Baweja, Raman
Mattison, Richard E.
Memon, Hasan
Klein, Melanie
Hameed, Usman
Waschbusch, Daniel
description •Psychotropic use was analyzed in 1407 children with autism and 1036 with ADHD.•Symptom scores for medicated children were far higher than for unmedicated children.•Percent prescribed a psychotropic did not differ between ADHD-Combined and autism.•Children with ADHD-Inattentive were least impaired and least likely to be medicated.•Medication classes prescribed differed between ADHD and autism. Most children with autism have ADHD, and children with ADHD-Combined and children with autism have high rates of irritable, oppositional, and aggressive behavior. Despite similar symptoms, prescribing practices may differ between autism and ADHD, which has not been examined in a single study. 1407 children with autism and 1036 with ADHD without autism, 2–17 years, were compared with 186 typical peers. Symptom scores were maternal Pediatric Behavior Scale ratings in eight areas (ADHD, oppositional/aggressive, irritable/angry, anxious, depressed, and social, writing, and learning problems). Psychotropics were prescribed to 38.0% with ADHD-Combined, 33.3% with autism, and 20.2% with ADHD-Inattentive, most often an ADHD medication (22.1% stimulant, 2.3% atomoxetine), antipsychotic (7.8%), SSRI (5.5%), and alpha agonist (4.9%). ADHD medications were more often prescribed than other medications in all diagnostic groups. Compared to autism, children with ADHD-Combined were more likely to be prescribed an ADHD medication, whereas antipsychotics and SSRIs were more likely to be prescribed in autism than in ADHD-Combined. Children with ADHD-Inattentive were least impaired and least likely to be medicated. More severely impaired children were more often medicated regardless of diagnosis. Symptom scores were far worse for treated and untreated children with ADHD and with autism than for typical peers.
doi_str_mv 10.1016/j.psychres.2020.112937
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2393638578</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165178119321444</els_id><sourcerecordid>2393638578</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3</originalsourceid><addsrcrecordid>eNqFkE1PAjEQhhujEUT_AunRy-K23d12bxJQMSHxIJ6b0p0NJftl28Xw7y1Z8Oplmkyed2b6IDQl8YzEJHvazzp31DsLbkZjGpqE5oxfoTERnEacUHaNxgFMI8IFGaE75_ZxHFOS57doxCgjqeDZGG0-j3Xn2xo73YZhWDUFrqEwWnnTNthbUL6GxuNOeQ-2cdg0WO9MVVho8I_xOzxfrpb4ANb1Id574-p7dFOqysHD-Z2gr9eXzWIVrT_e3hfzdaRZJnxUlEKHk4QAliahago0p6IkRSqyhFAtgPBtlqsSOMlVkpWpzgUHJhQpRVKwCXoc5na2_e7BeVkbp6GqVANt7yRlOcuYSLkIaDag2rbOWShlZ02t7FGSWJ6Myr28GJUno3IwGoLT845-G8T8xS4KA_A8ABB-ejBgpdMGGh0kWtBeFq35b8cv6h2LVQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2393638578</pqid></control><display><type>article</type><title>Symptom scores and medication treatment patterns in children with ADHD versus autism</title><source>ScienceDirect Freedom Collection</source><creator>Mayes, Susan D. ; Waxmonsky, James G. ; Baweja, Raman ; Mattison, Richard E. ; Memon, Hasan ; Klein, Melanie ; Hameed, Usman ; Waschbusch, Daniel</creator><creatorcontrib>Mayes, Susan D. ; Waxmonsky, James G. ; Baweja, Raman ; Mattison, Richard E. ; Memon, Hasan ; Klein, Melanie ; Hameed, Usman ; Waschbusch, Daniel</creatorcontrib><description>•Psychotropic use was analyzed in 1407 children with autism and 1036 with ADHD.•Symptom scores for medicated children were far higher than for unmedicated children.•Percent prescribed a psychotropic did not differ between ADHD-Combined and autism.•Children with ADHD-Inattentive were least impaired and least likely to be medicated.•Medication classes prescribed differed between ADHD and autism. Most children with autism have ADHD, and children with ADHD-Combined and children with autism have high rates of irritable, oppositional, and aggressive behavior. Despite similar symptoms, prescribing practices may differ between autism and ADHD, which has not been examined in a single study. 1407 children with autism and 1036 with ADHD without autism, 2–17 years, were compared with 186 typical peers. Symptom scores were maternal Pediatric Behavior Scale ratings in eight areas (ADHD, oppositional/aggressive, irritable/angry, anxious, depressed, and social, writing, and learning problems). Psychotropics were prescribed to 38.0% with ADHD-Combined, 33.3% with autism, and 20.2% with ADHD-Inattentive, most often an ADHD medication (22.1% stimulant, 2.3% atomoxetine), antipsychotic (7.8%), SSRI (5.5%), and alpha agonist (4.9%). ADHD medications were more often prescribed than other medications in all diagnostic groups. Compared to autism, children with ADHD-Combined were more likely to be prescribed an ADHD medication, whereas antipsychotics and SSRIs were more likely to be prescribed in autism than in ADHD-Combined. Children with ADHD-Inattentive were least impaired and least likely to be medicated. More severely impaired children were more often medicated regardless of diagnosis. Symptom scores were far worse for treated and untreated children with ADHD and with autism than for typical peers.</description><identifier>ISSN: 0165-1781</identifier><identifier>EISSN: 1872-7123</identifier><identifier>DOI: 10.1016/j.psychres.2020.112937</identifier><identifier>PMID: 32315876</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>ADHD-Combined ; ADHD-Inattentive ; Psychotropic medication ; Symptom profiles</subject><ispartof>Psychiatry research, 2020-06, Vol.288, p.112937-112937, Article 112937</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3</citedby><cites>FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32315876$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mayes, Susan D.</creatorcontrib><creatorcontrib>Waxmonsky, James G.</creatorcontrib><creatorcontrib>Baweja, Raman</creatorcontrib><creatorcontrib>Mattison, Richard E.</creatorcontrib><creatorcontrib>Memon, Hasan</creatorcontrib><creatorcontrib>Klein, Melanie</creatorcontrib><creatorcontrib>Hameed, Usman</creatorcontrib><creatorcontrib>Waschbusch, Daniel</creatorcontrib><title>Symptom scores and medication treatment patterns in children with ADHD versus autism</title><title>Psychiatry research</title><addtitle>Psychiatry Res</addtitle><description>•Psychotropic use was analyzed in 1407 children with autism and 1036 with ADHD.•Symptom scores for medicated children were far higher than for unmedicated children.•Percent prescribed a psychotropic did not differ between ADHD-Combined and autism.•Children with ADHD-Inattentive were least impaired and least likely to be medicated.•Medication classes prescribed differed between ADHD and autism. Most children with autism have ADHD, and children with ADHD-Combined and children with autism have high rates of irritable, oppositional, and aggressive behavior. Despite similar symptoms, prescribing practices may differ between autism and ADHD, which has not been examined in a single study. 1407 children with autism and 1036 with ADHD without autism, 2–17 years, were compared with 186 typical peers. Symptom scores were maternal Pediatric Behavior Scale ratings in eight areas (ADHD, oppositional/aggressive, irritable/angry, anxious, depressed, and social, writing, and learning problems). Psychotropics were prescribed to 38.0% with ADHD-Combined, 33.3% with autism, and 20.2% with ADHD-Inattentive, most often an ADHD medication (22.1% stimulant, 2.3% atomoxetine), antipsychotic (7.8%), SSRI (5.5%), and alpha agonist (4.9%). ADHD medications were more often prescribed than other medications in all diagnostic groups. Compared to autism, children with ADHD-Combined were more likely to be prescribed an ADHD medication, whereas antipsychotics and SSRIs were more likely to be prescribed in autism than in ADHD-Combined. Children with ADHD-Inattentive were least impaired and least likely to be medicated. More severely impaired children were more often medicated regardless of diagnosis. Symptom scores were far worse for treated and untreated children with ADHD and with autism than for typical peers.</description><subject>ADHD-Combined</subject><subject>ADHD-Inattentive</subject><subject>Psychotropic medication</subject><subject>Symptom profiles</subject><issn>0165-1781</issn><issn>1872-7123</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkE1PAjEQhhujEUT_AunRy-K23d12bxJQMSHxIJ6b0p0NJftl28Xw7y1Z8Oplmkyed2b6IDQl8YzEJHvazzp31DsLbkZjGpqE5oxfoTERnEacUHaNxgFMI8IFGaE75_ZxHFOS57doxCgjqeDZGG0-j3Xn2xo73YZhWDUFrqEwWnnTNthbUL6GxuNOeQ-2cdg0WO9MVVho8I_xOzxfrpb4ANb1Id574-p7dFOqysHD-Z2gr9eXzWIVrT_e3hfzdaRZJnxUlEKHk4QAliahago0p6IkRSqyhFAtgPBtlqsSOMlVkpWpzgUHJhQpRVKwCXoc5na2_e7BeVkbp6GqVANt7yRlOcuYSLkIaDag2rbOWShlZ02t7FGSWJ6Myr28GJUno3IwGoLT845-G8T8xS4KA_A8ABB-ejBgpdMGGh0kWtBeFq35b8cv6h2LVQ</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Mayes, Susan D.</creator><creator>Waxmonsky, James G.</creator><creator>Baweja, Raman</creator><creator>Mattison, Richard E.</creator><creator>Memon, Hasan</creator><creator>Klein, Melanie</creator><creator>Hameed, Usman</creator><creator>Waschbusch, Daniel</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202006</creationdate><title>Symptom scores and medication treatment patterns in children with ADHD versus autism</title><author>Mayes, Susan D. ; Waxmonsky, James G. ; Baweja, Raman ; Mattison, Richard E. ; Memon, Hasan ; Klein, Melanie ; Hameed, Usman ; Waschbusch, Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>ADHD-Combined</topic><topic>ADHD-Inattentive</topic><topic>Psychotropic medication</topic><topic>Symptom profiles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mayes, Susan D.</creatorcontrib><creatorcontrib>Waxmonsky, James G.</creatorcontrib><creatorcontrib>Baweja, Raman</creatorcontrib><creatorcontrib>Mattison, Richard E.</creatorcontrib><creatorcontrib>Memon, Hasan</creatorcontrib><creatorcontrib>Klein, Melanie</creatorcontrib><creatorcontrib>Hameed, Usman</creatorcontrib><creatorcontrib>Waschbusch, Daniel</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Psychiatry research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mayes, Susan D.</au><au>Waxmonsky, James G.</au><au>Baweja, Raman</au><au>Mattison, Richard E.</au><au>Memon, Hasan</au><au>Klein, Melanie</au><au>Hameed, Usman</au><au>Waschbusch, Daniel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Symptom scores and medication treatment patterns in children with ADHD versus autism</atitle><jtitle>Psychiatry research</jtitle><addtitle>Psychiatry Res</addtitle><date>2020-06</date><risdate>2020</risdate><volume>288</volume><spage>112937</spage><epage>112937</epage><pages>112937-112937</pages><artnum>112937</artnum><issn>0165-1781</issn><eissn>1872-7123</eissn><abstract>•Psychotropic use was analyzed in 1407 children with autism and 1036 with ADHD.•Symptom scores for medicated children were far higher than for unmedicated children.•Percent prescribed a psychotropic did not differ between ADHD-Combined and autism.•Children with ADHD-Inattentive were least impaired and least likely to be medicated.•Medication classes prescribed differed between ADHD and autism. Most children with autism have ADHD, and children with ADHD-Combined and children with autism have high rates of irritable, oppositional, and aggressive behavior. Despite similar symptoms, prescribing practices may differ between autism and ADHD, which has not been examined in a single study. 1407 children with autism and 1036 with ADHD without autism, 2–17 years, were compared with 186 typical peers. Symptom scores were maternal Pediatric Behavior Scale ratings in eight areas (ADHD, oppositional/aggressive, irritable/angry, anxious, depressed, and social, writing, and learning problems). Psychotropics were prescribed to 38.0% with ADHD-Combined, 33.3% with autism, and 20.2% with ADHD-Inattentive, most often an ADHD medication (22.1% stimulant, 2.3% atomoxetine), antipsychotic (7.8%), SSRI (5.5%), and alpha agonist (4.9%). ADHD medications were more often prescribed than other medications in all diagnostic groups. Compared to autism, children with ADHD-Combined were more likely to be prescribed an ADHD medication, whereas antipsychotics and SSRIs were more likely to be prescribed in autism than in ADHD-Combined. Children with ADHD-Inattentive were least impaired and least likely to be medicated. More severely impaired children were more often medicated regardless of diagnosis. Symptom scores were far worse for treated and untreated children with ADHD and with autism than for typical peers.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>32315876</pmid><doi>10.1016/j.psychres.2020.112937</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-1781
ispartof Psychiatry research, 2020-06, Vol.288, p.112937-112937, Article 112937
issn 0165-1781
1872-7123
language eng
recordid cdi_proquest_miscellaneous_2393638578
source ScienceDirect Freedom Collection
subjects ADHD-Combined
ADHD-Inattentive
Psychotropic medication
Symptom profiles
title Symptom scores and medication treatment patterns in children with ADHD versus autism
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T23%3A03%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Symptom%20scores%20and%20medication%20treatment%20patterns%20in%20children%20with%20ADHD%20versus%20autism&rft.jtitle=Psychiatry%20research&rft.au=Mayes,%20Susan%20D.&rft.date=2020-06&rft.volume=288&rft.spage=112937&rft.epage=112937&rft.pages=112937-112937&rft.artnum=112937&rft.issn=0165-1781&rft.eissn=1872-7123&rft_id=info:doi/10.1016/j.psychres.2020.112937&rft_dat=%3Cproquest_cross%3E2393638578%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2393638578&rft_id=info:pmid/32315876&rfr_iscdi=true